NLS Global report

As the coronavirus swept across the globe over the past year, science has been in the spotlight, sometimes embraced, sometimes vilified. The lackluster response by former US President Donald J. Trump’s administration to the coronavirus crisis at home and dismissal of much of the advice from science and health professionals contributed to hundreds of thousands […]

This event will offer a week of biotech, pharma and finance, including several very interesting on demand sessions. The digital event, October 25-28, will include one-to-one meetings, company presentations, company showcases and interesting keynotes and panels. Global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic […]

Following a 70-year effort, China has been awarded a malaria-free certification from WHO. This is a notable feat for a country that reported 30 million cases of the disease annually in the 1940s, the WHO states in a press release. “Today we congratulate the people of China on ridding the country of malaria,” says Dr […]

Aztiq Pharma Partners, a private equity fund led by Róbert Wessman, announced in the beginning of July that it has completed a 100 million USD financing to purchase a newly issued share equity in Alvogen US. Morgan Stanley led the financing, which was subscribed by international institutional investors. The capital was used by Aztiq to […]

Cytiva has acquired Intermountain Life Sciences, a manufacturer of high-purity water, buffers, and liquid cell culture media. Cytiva will use Intermountain’s manufacturing site in Utah to rapidly boost its liquid cell culture production by millions of liters. Hiring is ongoing to rapidly increase output, the company states in a press release. “The demand for buffers […]

JungJin SEO, Honorary Chairman of Celltrion Group, South Korea, has together with his colleagues developed drugs to treat cancer, autoimmune diseases and COVID-19. The entrepreneur JungJin SEO knew very little about science or medicine before founding a biopharmaceutical firm in 2003, describes EY in a press release. He studied Industrial Engineering but lost his job […]